About Jennifer Ahlstrom

Articles by Jennifer Ahlstrom

Bridging the Myeloma Treatment Gap: How Provider Education Improves Patient Access
Mar 06, 2025
HealthTree Foundation Launches AI-Powered Personalized Clinical Trial Finder
Mar 02, 2025
IMS 2024: New Strategies Using Immunotherapies in Myeloma Care
Oct 09, 2024
IMS 2024: News for High-Risk Multiple Myeloma
Oct 07, 2024
HealthTree Reports Live from Rio the Latest in Myeloma Research!
Oct 04, 2024
Can Yoga Help Myeloma Patients on Active Treatment?
Aug 29, 2024
When Does Smoldering Myeloma Become Active Myeloma?
Aug 27, 2024
What are ICD-10 Codes in Myeloma Insurance Billing?
Aug 21, 2024
What Are Neutrophils in Multiple Myeloma?
Aug 18, 2024
How Your T Cells Become Exhausted in Fighting Cancer
Aug 15, 2024
¿Por Qué Es Tan Complicado el Mieloma?
Aug 14, 2024
ASCO 2024: The More the Better in Newly Diagnosed Multiple Myeloma
Jul 10, 2024
Proteasome Inhibitors: Still a Powerful Weapon Against Myeloma
Jun 19, 2024
¿Cuál Es la Causa de Mi Cáncer?
Jun 11, 2024
Join us in Salt Lake City for a HealthTree Cure Tour with Dr. Douglas Sborov on July 2nd
Jun 06, 2024
ASCO 2024: A Phoenix Rising as Blenrep Shows Positive Data in Multiple Myeloma
Jun 03, 2024
HealthTree Cure Tour in Columbus on June 8th with Francesca Cottini
May 23, 2024
ASH 2020: Uso Real de las Pruebas de Enfermedad Mínima Residual (EMR) en el Mieloma Múltiple
May 14, 2024
Is Multiple Myeloma Genetic?
May 09, 2024
¿Cómo Toma Decisiones En una Recaída de Mieloma? Por Favor, Comparta Su Experiencia.
May 07, 2024
What are Myeloma Treatment Response Levels?
May 02, 2024
HealthTree Cure Tour in Dallas on May 7th and Houston on May 9th
May 01, 2024
¿Qué Es la Anemia En el Mieloma?
Apr 29, 2024
What is a "Line" of Therapy in Multiple Myeloma?
Apr 29, 2024